Pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome

Pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome (also known as pigmented hypertrichosis-insulin-dependent diabetes mellitus syndrome or PHID syndrome) is an extremely rare genetic disorder characterized by the combination of generalized hypertrichosis (excessive hair growth), hyperpigmentation of the skin, and insulin-dependent diabetes mellitus that typically develops in childhood. The condition affects the integumentary system (skin and hair) and the endocrine system (pancreas and glucose metabolism). Affected individuals present with diffuse darkening of the skin and excessive body hair growth that is apparent from early life. The diabetes component is insulin-dependent, resembling type 1 diabetes, and requires lifelong insulin therapy for glucose management. Additional features that have been reported in some patients include hepatomegaly (enlarged liver) and other variable findings. The syndrome has been described in a very small number of families, and consanguinity in affected families has suggested an autosomal recessive inheritance pattern. There is currently no cure or disease-specific treatment for this syndrome. Management is supportive and symptom-based, focusing primarily on insulin therapy for diabetes control, dermatologic management of hypertrichosis and hyperpigmentation, and regular monitoring for potential complications. Genetic counseling is recommended for affected families.

Common questions about Pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome